Improved 5-year survival was seen in primary melanomas with high stromal PDCD4 expression (log-rank test, p = 0.045, RR 0.738; Lower CL 0.54; Upper CL 0.98, p = 0.042), Figure 3a. Here, PDCD4 is linked to melanoma.